Oogcentrum Noordholland Acquires Okulus to Expand Digital Eye Care

Oogcentrum Noordholland has acquired Okulus, a Dutch digital platform connecting patients with over 400 eye care specialists across approximately 350 locations. The acquisition, announced on July 9, 2026, marks a strategic step to combine clinical expertise with innovative digital solutions to improve accessibility, efficiency, and affordability in eye care.

While financial terms were not disclosed, the transaction involves the transfer of ownership to Dr. Rob Wouters, founder of Oogcentrum Noordholland, who will lead Okulus through its next growth phase. The deal was advised by InCorpe | focus on value, with Tim Posthuma and Ruben Engbers providing advisory and financing structuring support.

Oogcentrum Noordholland is a prominent ophthalmology expertise center in the Netherlands, known for its sustainable and innovative approach with a strong patient focus. Okulus, founded by ophthalmologists, operates a digital platform designed to streamline patient access to eye care specialists nationwide, enhancing service reach and coordination.

The acquisition aims to create synergies by integrating Oogcentrum Noordholland’s clinical expertise with Okulus’s digital infrastructure. This combination is expected to facilitate cross-selling of complementary services, expand patient referrals, and jointly develop innovative eye care solutions. Operational efficiencies are anticipated through shared administrative functions, consolidated procurement, and optimized use of clinical equipment.

Industry trends show increasing demand for accessible and patient-centric eye care solutions, driven by aging populations and technological advancements. This consolidation strengthens regional leadership in ophthalmology, positioning the combined entity to better compete amid accelerating healthcare sector consolidation.

Financial details such as deal value and multiples remain undisclosed. The acquisition was supported by InCorpe, which advised on deal structuring and financing, ensuring alignment with strategic growth objectives.

Looking ahead, integration efforts will focus on aligning organizational cultures, securely merging IT systems and patient data, and maintaining high service quality. Regulatory compliance remains a key consideration during the transition. The combined organization plans to leverage its enhanced capabilities to innovate and expand patient access across the Netherlands.

Overall, this acquisition represents a strategic consolidation aimed at driving growth, improving patient outcomes, and fostering innovation in Dutch eye care services.